Health System Builds Telehealth Network; Sees Great Return on Investment

Source: Healthcare Finance News, Erin McCann (5/22/12)

"Polycom, a video conference and communications company, is helping Saint Vincent Health System build a telehealth network by visually connecting healthcare professionals and patients in virtual environments across 26 facilities in Pennsylvania."

Healthcare Finance News, Erin McCann

Bluetooth-capable stethoscopes, allowing doctors to hear heart sounds from across the country, are just one innovation Saint Vincent Health System is using in its new telehealth network, which has reduced hospital readmissions and generated a 100 percent ROI in less than two months, officials say.

Pleasanton, Calif.-based Polycom, a video conference and communications company, is helping Saint Vincent Health System build a telehealth network with technology that seeks to make healthcare more accessible by visually connecting healthcare professionals and patients in virtual environments across 26 facilities in Pennsylvania. . .View Full Article

Healthcare Firm Uncovers AI Healthcare Growth Opportunity
Source: Streetwise Reports (06/06/2025)

Treatment.com AI Inc.'s (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) subsidiary Rocket Doctor was chosen by the Larta Institute to participate in its Bioscience and Healthcare Accelerator program. Read on to learn why one analyst says it is time to buy this company's stock.

Co. Poised to Begin Major New Bull Market
Source: Clive Maund (05/23/2025)

Technical Analyst Clive Maund explains why he thinks Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGW0:XFRA) is an Immediate Strong Buy.

Centrally Positioned AI Co. Platform Designed To Transform Healthcare
Source: Clive Maund (05/21/2025)

Technical Analyst Clive Maund explains why he thinks now is an excellent time to buy or add to positions in Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA).

Biopharma Company Leverages AI-Powered Platform for Cancer Breakthroughs
Source: Streetwise Reports (04/24/2025)

Rakovina Therapeutics Inc. (RKV:TSX.V) announced its scientific advisor and collaborator Dr. Artem Cherkasov was recently recognized as a leader in AI-driven drug development. Find out which analysts recently initiated coverage on the company.

Two Use Cases for AI in Healthcare
Source: Streetwise Reports (03/14/2025)

In both, proprietary software platforms analyze heaps of data, but one focuses on genetics, the other neurology. Learn more about the companies behind the technology.